Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Y Wei, L Chang, K Hashimoto - Molecular psychiatry, 2022‏ - nature.com
The discovery of robust antidepressant actions exerted by the N-methyl-D-aspartate receptor
(NMDAR) antagonist (R, S)-ketamine has been a crucial breakthrough in mood disorder …

[HTML][HTML] The chronic mild stress (CMS) model of depression: History, evaluation and usage

P Willner - Neurobiology of stress, 2017‏ - Elsevier
Now 30 years old, the chronic mild stress (CMS) model of depression has been used in>
1300 published studies, with a year-on-year increase rising to> 200 papers in 2015. Data …

Cortisol and major depressive disorder—translating findings from humans to animal models and back

LS Nandam, M Brazel, M Zhou, DJ Jhaveri - Frontiers in psychiatry, 2020‏ - frontiersin.org
Major depressive disorder (MDD) is a global problem for which current pharmacotherapies
are not completely effective. Hypothalamic–pituitary–adrenal (HPA) axis dysfunction has …

The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders

GZ Réus, GR Fries, L Stertz, M Badawy, IC Passos… - Neuroscience, 2015‏ - Elsevier
Psychiatric disorders, including major depressive disorder (MDD), bipolar disorder (BD) and
schizophrenia, affect a significant percentage of the world population. These disorders are …

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure

N Li, RJ Liu, JM Dwyer, M Banasr, B Lee, H Son… - Biological …, 2011‏ - Elsevier
BACKGROUND: Despite widely reported clinical and preclinical studies of rapid
antidepressant actions of glutamate N-methyl-D-aspartate (NMDA) receptor antagonists …

Neuroinflammation and comorbidity of pain and depression

AK Walker, A Kavelaars, CJ Heijnen, R Dantzer - Pharmacological reviews, 2014‏ - Elsevier
Comorbid depression and chronic pain are highly prevalent in individuals suffering from
physical illness. Here, we critically examine the possibility that inflammation is the common …

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

FX Vollenweider, M Kometer - Nature Reviews Neuroscience, 2010‏ - nature.com
After a pause of nearly 40 years in research into the effects of psychedelic drugs, recent
advances in our understanding of the neurobiology of psychedelics, such as lysergic acid …

Inflammation, stress and depression: an exploration of ketamine's therapeutic profile

JN Johnston, MS Greenwald, ID Henter, C Kraus… - Drug discovery today, 2023‏ - Elsevier
Highlights•Chronic stress, depression and inflammation have been consistently
linked.•Stress-induced inflammatory states can contribute to treatment resistance.•Ketamine …

Neurobiology of chronic mild stress: parallels to major depression

MN Hill, KGC Hellemans, P Verma, BB Gorzalka… - Neuroscience & …, 2012‏ - Elsevier
The chronic mild (or unpredictable/variable) stress (CMS) model was developed as an
animal model of depression more than 20 years ago. The foundation of this model was that …

Current status of animal models of posttraumatic stress disorder: behavioral and biological phenotypes, and future challenges in improving translation

J Deslauriers, M Toth, A Der-Avakian, VB Risbrough - Biological psychiatry, 2018‏ - Elsevier
Increasing predictability of animal models of posttraumatic stress disorder (PTSD) has
required active collaboration between clinical and preclinical scientists. Modeling PTSD is …